Publication | Open Access

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

VaccinologyVaccine SafetyVaccinationVaccine DevelopmentImmunologyVaccine TrialPlacebo-controlled TrialVaccine EfficacyCovid-19 EpidemiologyPhase 2MedicineCovid-19